文献速递中毒与环境急症心脑血管急症

安非他酮过量后心率对临床病程的预测价值

The predictive value of heart rate in determining clinical course after a bupropion overdose.
PubMed 文献 · Clin Toxicol (Phila) · 2024-05-23
一句话结论安非他酮过量后8小时内最大心率<104次/分对迟发不良结局阴性预测值100%,支持8小时观察期(作者结论)。

该回顾性队列研究纳入2010至2022年间两家医院系统的216例超治疗剂量安非他酮病例,评估就诊后8小时内最大心率能否识别无需延长观察的低风险患者。结果显示癫痫发作占19%(n=41)、低血压占1.4%(n=3)、心律失常占0.9%(n=2),1例死亡;迟发不良效应罕见(n=4),发生于摄入后14至28小时。8小时内最大心率与不良结局风险相关(OR 1.07;95%CI 1.05–1.09;P<0.001);8小时最大心率阈值104次/分对迟发不良效应的阴性预测值为100%(95%CI 96.7%–100%)。所有出现迟发效应的患者在到达急诊后5小时内均有心动过速。作者认为该研究支持在无其他中毒临床征象、无共摄入或服用掩盖心动过速物质时采用8小时观察期。

要点

  • 8小时最大心率阈值104次/分对迟发不良效应的阴性预测值为100%(95%CI 96.7%–100%)。
  • 8小时内最大心率与不良结局风险相关(OR 1.07;95%CI 1.05–1.09;P<0.001)。
  • 迟发不良效应罕见(n=4),发生于摄入后14至28小时;所有出现迟发效应的患者在到达急诊后5小时内均有心动过速。
  • 队列中癫痫发作占19%(n=41)、低血压占1.4%(n=3)、心律失常占0.9%(n=2),1例死亡。
  • 作者结论支持:无其他中毒临床征象、无共摄入或服用掩盖心动过速物质时,采用8小时观察期。

适用人群与场景

  • 2010至2022年间两家医院系统的所有超治疗剂量安非他酮病例(回顾性队列,n=216)。

诊断标准与关键阈值

  • 8小时最大心率阈值104次/分用于筛查迟发不良效应低风险患者,阴性预测值100%(95%CI 96.7%–100%)。

处置流程与药物剂量

  • 作者结论支持:无其他中毒临床征象、无共摄入或服用掩盖心动过速的物质时,采用8小时观察期。

红旗征与不能漏的情况

  • 迟发不良效应包括癫痫发作、低血压、心律失常和死亡,发生于摄入后14至28小时。
  • 所有出现迟发效应的患者在到达急诊后5小时内均有心动过速。

研究设计与关键结果

  • 回顾性队列研究,纳入两家医院系统2010至2022年216例超治疗剂量安非他酮病例。
  • 癫痫发作占19%(n=41),低血压占1.4%(n=3),心律失常占0.9%(n=2),1例死亡。
  • 迟发不良效应罕见(n=4),发生于摄入后14至28小时。
  • 8小时内最大心率与不良结局风险相关(OR 1.07;95%CI 1.05–1.09;P<0.001)。
  • 8小时最大心率阈值104次/分对迟发不良效应的阴性预测值为100%(95%CI 96.7%–100%)。
  • 所有出现迟发效应的患者在到达急诊后5小时内均有心动过速。

证据类型、等级与局限

  • 证据类型:回顾性队列研究。
  • 局限:回顾性设计;多数病例无法确定摄入时间;缺乏确证性实验室检测。

对床旁实践的改变

  • 作者认为:8小时内心率可作为筛查工具识别迟发不良结局低风险患者,支持在无其他中毒临床征象、无共摄入或服用掩盖心动过速物质时采用8小时观察期。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: Bupropion is a popular antidepressant due to its favorable side effect profile and indications for smoking cessation and weight loss. Due to the possibility of delayed onset seizure and other adverse outcomes after bupropion overdose, patients are often observed for periods of 12-24 hours following suspected ingestion. Tachycardia is a clinical predictor that holds promise in differentiating cases at risk for seizures from low-risk cases that do not require prolonged observation. This study assessed whether heart rate within the first eight hours of presentation can identify cases that do not require extended observation.

METHODS: This is a retrospective cohort study of all supra-therapeutic bupropion cases from two hospital systems between 2010 and 2022.

RESULTS: Data from 216 charts were included. Seizures, hypotension, and dysrhythmias occurred in 19 percent (n = 41), 1.4 percent (n = 3), 0.9 percent (n = 2) respectively. One patient died. Delayed adverse effects were rare (n = 4); they occurred from 14 hours to 28 hours post-ingestion. Maximum heart rate in eight hours was associated with a risk of adverse outcomes. (odds ratio, 1.07; 95 percent confidence interval: 1.05 to 1.09; P < 0.001). An eight hour maximum heart rate threshold of 104 beats/minute had a negative predictive value of 100 percent (95 percent confidence interval: 96.7 percent to 100 percent) for the occurrence of delayed adverse effects. All patients with delayed effects had tachycardia within five hours of emergency department arrival.

DISCUSSION: Delayed adverse outcomes of seizures, hypotension, dysrhythmia, and death were uncommon in this cohort. Heart rate during the first eight hours of observation performs reliably as a screening test to identify patients at low risk for delayed adverse outcomes. This study is limited by its retrospective nature, the inability to ascertain time of ingestion for most cases and the lack of confirmatory laboratory testing.

CONCLUSION: This study supports the use of an eight hour observation period when there are no other clinical signs of toxicity to warrant admission and if no co-ingestion or administration of substances that mask tachycardia are present.

来源:Clin Toxicol (Phila),查看原文。版权归原作者所有。

参考来源

  1. Idowu D, Ezema K, Corcoran J, et al. The predictive value of heart rate in determining clinical course after a bupropion overdose. Clin Toxicol (Phila). 2024. PMID: 38780445. doi:10.1080/15563650.2024.2347514

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。